Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current status and future development of antitubercular chemotherapy.

Expert opinion on investigational drugs - 1 Aug 2002

Kremer Laurent S, Besra Gurdyal S

Abstract excerpt

Tuberculosis (TB), which kills more people than any other infectious disease, was declared a global emergency by the World Health Organization in 1993. The emergence of new Mycobacterium tuberculosis strains that are resistant to some or all current antitubercular drugs seriously hampers the cont...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Drug Design
Share to Genes, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Mycobacterium tuberculosis

Share to Tuberculosis, Multidrug-Resistant

Source

Identifiers

PMID: 12150700
DOI: 10.1517/13543784.11.8.1033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-12150700-2026-09-02.1. Manifest publication-graph-cohort-2026-09-02.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current status and future development of antitubercular chemotherapy.PMID 12150700Read ↗

Mycobacterial cell wall biosynthesis: a multifaceted antibiotic targetSemantic proximity Read ↗

Cell Surface Biosynthesis and Remodeling Pathways in Mycobacteria Reveal New Drug TargetsSemantic proximity Read ↗

Revisiting Anti-tuberculosis Therapeutic Strategies That Target the Peptidoglycan Structure and SynthesisSemantic proximity Read ↗

Antibiotics and resistance: the two-sided coin of the mycobacterial cell wallSemantic proximity Read ↗

Cell Wall Associated Factors of Mycobacterium tuberculosis as Major Virulence Determinants: Current Perspectives in Drugs Discovery and DesignSemantic proximity Read ↗

Target Identification in Anti-Tuberculosis Drug DiscoverySemantic proximity Read ↗

Future directions in the development of new antitubercular drugs. Where do we go from here?Semantic proximity Read ↗

The past, present and future of tuberculosis treatment.Semantic proximity Read ↗

Mycobacterial ethambutol responsive genes and implications in antibiotics resistance.Semantic proximity Read ↗

Synthesis and Biological Aspects of Mycolic Acids: An Important Target Against<i>Mycobacterium tuberculosis</i>Semantic proximity Read ↗

New structural classes of antituberculosis agentsSemantic proximity Read ↗

Thiacetazone, an Antitubercular Drug that Inhibits Cyclopropanation of Cell Wall Mycolic Acids in MycobacteriaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.